PGS Publication: PGP000727

Publication Information (EuropePMC)
Title Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women.
PubMed ID 38422475(Europe PMC)
doi 10.1200/jco.23.00295
Publication Date Feb. 29, 2024
Journal J Clin Oncol
Author(s) Mars N, Kerminen S, Tamlander M, Pirinen M, Jakkula E, Aaltonen K, Meretoja T, Heinävaara S, Widén E, Ripatti S, FinnGen.
Released in PGS Catalog: May 20, 2025

Associated Polygenic Score(s)

Filter PGS by Participant Ancestry
Individuals included in:
G - Source of Variant Associations (GWAS)
D - Score Development/Training
E - PGS Evaluation
List of ancestries includes:
Display options:
Ancestry legend
Multi-ancestry (including European)
Multi-ancestry (excluding European)
African
East Asian
South Asian
Additional Asian Ancestries
European
Greater Middle Eastern
Hispanic or Latin American
Additional Diverse Ancestries
Not Reported

External PGS Evaluated By This Publication

Polygenic Score ID & Name PGS Publication ID (PGP) Reported Trait Mapped Trait(s) (Ontology) Number of Variants Ancestry distribution
GWAS
Dev
Eval
Scoring File (FTP Link)
PGS000335
(BC_PRSCS)
PGP000102 |
Mars N et al. Nat Commun (2020)
Breast cancer breast carcinoma 1,079,089
-
https://ftp.ebi.ac.uk/pub/databases/spot/pgs/scores/PGS000335/ScoringFiles/PGS000335.txt.gz

Performance Metrics

Disclaimer: The performance metrics are displayed as reported by the source studies. It is important to note that metrics are not necessarily comparable with each other. For example, metrics depend on the sample characteristics (described by the PGS Catalog Sample Set [PSS] ID), phenotyping, and statistical modelling. Please refer to the source publication for additional guidance on performance.

PGS Performance
Metric ID (PPM)
Evaluated Score PGS Sample Set ID
(PSS)
Performance Source Trait PGS Effect Sizes
(per SD change)
Classification Metrics Other Metrics Covariates Included in the Model PGS Performance:
Other Relevant Information
PPM022574 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: Invasive breast cancer (before screening age) HR: 1.75 [1.66, 1.84] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.
PPM022575 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: In situ breast cancer (before screening age) HR: 2.39 [1.91, 3.0] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.
PPM022573 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: Any breast cancer (before screening age) HR: 1.78 [1.69, 1.87] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.
PPM022576 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: Any breast cancer (during screening age) HR: 1.66 [1.63, 1.7] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.
PPM022577 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: Invasive breast cancer (during screening age) HR: 1.67 [1.63, 1.71] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.
PPM022578 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: In situ breast cancer (during screening age) HR: 1.73 [1.61, 1.86] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.
PPM022579 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: Bilateral breast cancer (during screening age) HR: 2.49 [2.03, 3.05] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.
PPM022580 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: Any breast cancer (after screening age) HR: 1.63 [1.56, 1.7] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.
PPM022581 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: Invasive breast cancer (after screening age) HR: 1.64 [1.57, 1.71] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.
PPM022582 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: In situ breast cancer (after screening age) HR: 1.58 [1.33, 1.87] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.
PPM022583 PGS000335
(BC_PRSCS)
PSS012022|
European Ancestry|
117,252 individuals
PGP000727 |
Mars N et al. J Clin Oncol (2024)
|Ext.
Reported Trait: Bilateral breast cancer (after screening age) HR: 2.75 [1.96, 3.85] birth year, genotyping array, subcohort, and the first 10 principal components of genetic ancestry.

Evaluated Samples

PGS Sample Set ID
(PSS)
Phenotype Definitions and Methods Participant Follow-up Time Sample Numbers Age of Study Participants Sample Ancestry Additional Ancestry Description Cohort(s) Additional Sample/Cohort Information
PSS012022
[
  • 11,556 cases
  • , 105,696 controls
]
,
0.0 % Male samples
European FinnGen